Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Medicare beneficiaries who take a lot of pricey medications will get a big break come 2025. That’s when the $2,000 annual cap ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

The increases are to list prices, which do not include rebates to pharmacy benefit managers and other discounts. Larger drug price increases were once far more common in the U.S. but in recent ...

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...

These three countries are among the top five which the U.S. imports pharmaceuticals, creating uncertainty for medication prices and availability. Higher tariffs would affect about 75% of medical ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...

Medicare beneficiaries who take a lot of pricey medications will get a big break in 2025. That's when the $2,000 annual cap on out-of-pocket costs for drugs bought at the pharmacy or through mail ...

NEW YORK (Reuters) - Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, Bristol Myers Squibb's cancer cell therapies and ...

"The cap offers some peace of mind that you won't have to leave the pharmacy empty handed ... Biden administration announces 1st drugs subject to Medicare price negotiations: List The subsidy ...